Trials / Completed
CompletedNCT02631863
Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
A Pilot Study of Photodynamic Therapy (PDT) Using Aminolaevulinic Acid (ALA) in Patients With HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This trial will study the effectiveness of photodynamic therapy with aminolaevulinic acid for the treatment of patients with HPV+ low grade cervical intraepithelial neoplasia (LSIL;CIN1).
Conditions
- Cervical Intraepithelial Neoplasia
- Low-Grade Squamous Intraepithelial Lesions
- Papillomavirus Infections
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aminolaevulinic acid | Aminolaevulinic acid with illumination |
| DRUG | Placebo | Placebo with illumination |
Timeline
- Start date
- 2016-03-22
- Primary completion
- 2018-11-24
- Completion
- 2018-11-24
- First posted
- 2015-12-16
- Last updated
- 2019-07-08
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02631863. Inclusion in this directory is not an endorsement.